GLP-1 receptor agonists (GLP-1RAs), beyond their well-established role in regulating blood sugar levels, represent a promising area of research related to their effects on brain function, and they can demonstrate benefits in the context of Alzheimer’s disease and Parkinson’s disease [122,123,124,125]. This evidence concerns the gene GLP1R and early-onset autosomal dominant Alzheimer disease.